Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Oxacillin mixture with viomycin
RN: 23284-14-2
InChIKey: ZULRFDNPEFIZQF-UHQLVPBSSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C25-H43-N13-O10.3C19-H19-N3-O5-S

Molecular Weight

  • 1815.9372
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Oxacillin mixture with viomycin

Synonyms

  • Oxacillin / viomycin
  • Viomycin 3-phenyl-5-methyl-4-isoxazolylpenicillinate

Systematic Names

  • 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamido)-7-oxo-, compd. with viomycin (3:1)
  • Viomycin, tris(3,3-dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamido)-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate) (salt)

Registry Numbers

CAS Registry Number

  • 23284-14-2

System Generated Number

  • 0023284142

Molecular Formulas

Molecular Formula

  • C25-H43-N13-O10.3C19-H19-N3-O5-S

Molecular Formula Fragments

  • C19-H19-N3-O5-S
  • C25-H43-N13-O10
  • COMPONENT

Structure Descriptors

InChI

1S/C51H55N9O15S3.C25H43N13O10/c1-19-25(37(61)52-31-40(64)58-34(46(67)68)49(4,5)76-43(31)58)28(55-73-19)22-13-11-10-12-14-23(29-26(20(2)74-56-29)38(62)53-32-41(65)59-35(47(69)70)50(6,7)77-44(32)59)16-18-24(17-15-22)30-27(21(3)75-57-30)39(63)54-33-42(66)60-36(48(71)72)51(8,9)78-45(33)60;26-3-1-2-10(27)4-16(41)32-12-6-30-23(47)18(11-5-17(42)37-24(28)36-11)38-20(44)13(7-31-25(29)48)33-21(45)14(8-39)35-22(46)15(9-40)34-19(12)43/h11,13-15,18,31-36,43-45H,10,12,16-17H2,1-9H3,(H,52,61)(H,53,62)(H,54,63)(H,67,68)(H,69,70)(H,71,72);7,10-12,14-15,17-18,39-40,42H,1-6,8-9,26-27H2,(H,30,47)(H,32,41)(H,33,45)(H,34,43)(H,35,46)(H,38,44)(H3,28,36,37)(H3,29,31,48)/b13-11-,22-15+,23-14+,24-18+;13-7-/t31-,32-,33-,34+,35+,36+,43-,44-,45-;10-,11+,12-,14-,15-,17-,18-/m10/s1

InChIKey

ZULRFDNPEFIZQF-UHQLVPBSSA-N

Smiles

Cc1onc(\C\2=C\CC\C=C/C(=C\C\C(=C/C2)\c3noc(C)c3C(=O)N[C@H]4[C@H]5SC(C)(C)[C@@H](N5C4=O)C(=O)O)/c6noc(C)c6C(=O)N[C@H]7[C@H]8SC(C)(C)[C@@H](N8C7=O)C(=O)O)c1C(=O)N[C@H]9[C@H]%10SC(C)(C)[C@@H](N%10C9=O)C(=O)O.NCCC[C@H](N)CC(=O)N[C@H]%11CNC(=O)[C@@H](NC(=O)\C(=C\NC(=O)N)\NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC%11=O)[C@H]%12C[C@H](O)N=C(N)N%12

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 520mg/kg (520mg/kg)   Acta Poloniae Pharmaceutica Vol. 26, Pg. 29, 1969.